购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

PROTAC-Linker Conjugates for PAC

PROTAC-Antibody Conjugates (PACs) are an innovative class of therapeutic agents that combine the specificity of antibodies with the protein-degrading capabilities of PROTACs (Proteolysis-Targeting Chimeras). This combination allows for the targeted degradation of disease-causing proteins, offering a promising approach for treating various diseases, including cancer and autoimmune disorders.

  • PROTAC BRD4 degrader for PAC-1
    T18603
    PROTAC BRD4 degrader for PAC-1 (compound 5) is a chimeric BET degrader GNE-987 conjugated with a disulfide-containing linker[1]. This PROTAC-linker conjugate specifically targets and degrades BRD4, enabling selective proteolysis of PAC-1.
    • 询价
    规格
    数量
  • PAC
    T185142158322-33-7
    PAC is a chemical conjugate consisting of an ADCs linker and PROTACs linked to an antibody. When PAC is conjugated to an antibody, it exhibits enhanced degradation of estrogen receptor-alpha (ERα) in comparison to PROTAC alone.
    • 询价
    规格
    数量
  • MC-(β-Ala)-PABC-(β-D-GlcUA)-amide-PEG1-CH2-CC-885
    T877082722697-86-9
    Comp Ie (MC-(β-Ala)-PABC-(β-D-GlcUA)-amide-PEG1-CH2-CC-885) 为一种新型抗体新降解剂偶联活性分子 (AnDC) 的合成降解剂偶联物。
    • 询价
    待询
    规格
    数量